Exposure to phenobarbitone during pregnancy can cause birth defects, including facial and digital anomalies and developmental delays. This case highlights the teratogenic risks of anticonvulsants and suggests safer treatment guidelines for pregnant individuals.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: